Structural basis of phospholipid sensing nuclear receptor LRH-1 recognition by carboxylic acid bioisosteres reveals an alternative ligand interaction site.
Bhowmik, D., Cato, M.L., Abraham, S.M., Spurlin, R.M., Flynn, A.R., Colucci, J.K., Mays, S., D'Agostino, E.H., Johnson, A.M., Jui, N.T., Calvert, J., Ortlund, E.A.(2026) J Biol Chem : 113731-113731
- PubMed: 42982175 Search on PubMed
- DOI: https://doi.org/10.1016/j.jbc.2026.113731
- Primary Citation Related Structures: 
39IW - PubMed Abstract: 
Liver receptor homolog-1 (LRH-1; NR5A2) is a phospholipid-sensing nuclear receptor that regulates metabolic and steroidogenic pathways in the liver, intestine, and pancreas. Previously, we showed that small-molecule LRH-1 agonists with carboxylic acid "tails" mimic endogenous phospholipid contacts at the mouth of the ligand-binding pocket, enhancing receptor activation. To improve metabolic stability while preserving these key interactions, we designed a series of agonists in which the carboxylate was replaced with bioisosteric polar groups. Substituting a tetrazole for the carboxylate in a lead agonist preserved high affinity LRH-1 binding, improved potency in cellular reporter assays, and promoted stronger target gene induction. Incorporation of a sulfamide moiety to promote interactions in the deep part of the LRH-1 binding pocket yielded a dual-modified agonist (6NTet) with further gains in affinity and activity. Crystal structures, molecular dynamics simulations, and mutational analyses revealed that the 6NTet tetrazole tail dynamically samples two distinct interaction sites within the LRH-1 ligand-binding pocket. One site corresponds to a previously characterized region engaged by phospholipid ligands and synthetic carboxylate-containing agonists (site 1), whereas the second represents a previously unrecognized interaction site (site 2). Mutational analyses demonstrated that both sites contribute to agonist-induced receptor activation, while site 2 additionally influences basal LRH-1 activity. Together, these findings establish tetrazole substitution as an effective strategy for improving phospholipid-mimetic LRH-1 agonists and identify 6NTet as a promising lead compound. The discovery of a novel ligand interaction site further expands our understanding of LRH-1 activation and provides a framework for next-generation agonist design.
- Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Organizational Affiliation: 


